Cargando…
Arsenic Primes Human Bone Marrow CD34+ Cells for Erythroid Differentiation
Arsenic trioxide exhibits therapeutic effects on certain blood malignancies, at least partly by modulating cell differentiation. Previous in vitro studies in human hematopoietic progenitor cells have suggested that arsenic may inhibit erythroid differentiation. However, these effects were all observ...
Autores principales: | Zhang, Yuanyuan, Wang, Shasha, Chen, Chunyan, Wu, Xiao, Zhang, Qunye, Jiang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480244/ https://www.ncbi.nlm.nih.gov/pubmed/26170775 http://dx.doi.org/10.1155/2015/751013 |
Ejemplares similares
-
Human Cord Blood and Bone Marrow CD34+ Cells Generate Macrophages That Support Erythroid Islands
por: Belay, Eyayu, et al.
Publicado: (2017) -
Immunoregulatory properties of erythroid nucleated cells induced from CD34+ progenitors from bone marrow
por: Shevchenko, Julia A., et al.
Publicado: (2023) -
Bone marrow sinusoidal endothelium controls terminal erythroid differentiation and reticulocyte maturation
por: Heil, Joschka, et al.
Publicado: (2021) -
T lymphocyte differentiation in vitro from adult human prethymic CD34+ bone marrow cells
Publicado: (1993) -
Arsenite exposure inhibits the erythroid differentiation of human hematopoietic progenitor CD34(+) cells and causes decreased levels of hemoglobin
por: Wan, Guanghua, et al.
Publicado: (2021)